Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats. (2021)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05150-7
PubMed Identifier: 33691748
Publication URI: http://europepmc.org/abstract/MED/33691748
Type: Journal Article/Review
Volume: 22
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215